<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-105084</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:creator>Palomer, Xavier</dc:creator>
<dc:language>es</dc:language>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);24(2): 112-113, mar.-abr. 2012.</dc:source>
<dc:identifier>ibc-105084</dc:identifier>
<dc:title xml:lang="es">La inhibición de miR-33a/b en primatesno humanos incrementa los nivelesplasmáticos de HDL y disminuye los triglicéridos de VLDL</dc:title>
<dc:subject>^d11759</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d4255</dc:subject>
<dc:subject>^d37535^s22006</dc:subject>
<dc:subject>^d8250^s22062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201204</dc:date>
</metadata>
</record>
</ibecs-document>
